HIV 1 News and Research

RSS

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

Researchers discover genetic risk factor for premature birth

Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth.

7 May 2014

New United Nations data show sharp decline in maternal deaths

New United Nations data show a 45% reduction in maternal deaths since 1990. An estimated 289 000 women died in 2013 due to complications in pregnancy and childbirth, down from 523 000 in 1990.

6 May 2014

Nanoviricides develops new drug candidates against MERS infection

...

6 May 2014

The Jeffrey Epstein VI Foundation supports Sunscreen Innovation Act to combat melanoma

Sunscreens are long overdue for a makeover: in fact active ingredients in US sunscreens haven't been updated for fifteen years, despite dermatologist and oncologist warnings that US sunscreens are not effective enough.

6 May 2014

Highlights: High Colo. insurance rate changes; La. hospital plan rejected; VA delays in care

A selection of health policy stories from Colorado, Louisiana, Arizona, California, Florida and Michigan.

6 May 2014

Women who experience physical violence by partner are more likely to be smokers

One third of women around the world have experienced physical or sexual violence at the hands of their intimate partners with consequences from post-traumatic stress disorder, anxiety, and depression, to sexually transmitted diseases, including HIV.

6 May 2014

Compounds in soy sauce can be 70 times more potent than first-line HIV drug Tenofovir

For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications.

6 May 2014

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

Consumption of alcohol has long been associated with an increased risk of advanced liver fibrosis, but a new study published online in Clinical Infectious Diseases from researchers at Penn Medicine and other institutions shows that association is drastically heightened in people co-infected with both HIV and chronic hepatitis C virus (HCV) infection.

5 May 2014

New technique to examine how proteins interact at level of single HIV viral particle

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle.

5 May 2014

Puzzle in breast cancer solved

In a new study published in Cell Reports, scientists at the Fred Hutchinson Cancer Research Center demonstrate that mice lacking one copy of a gene called CTCF have abnormal DNA methylation and are markedly predisposed to cancer.

5 May 2014

UAMS receives $1.8M grant to lead new treatments for herpes viruses and cancers

A surprise discovery that could lead to new treatments for herpes viruses that infect more than 90 percent of the world's adult population has led to a $1.8 million grant to the University of Arkansas for Medical Sciences (UAMS) from the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

5 May 2014

Johns Hopkins biochemists figure out HIV-fighting activity of enzyme

Johns Hopkins biochemists have figured out what is needed to activate and sustain the virus-fighting activity of an enzyme found in CD4+ T cells, the human immune cells infected by HIV. The discovery could launch a more effective strategy for preventing the spread of HIV in the body with drugs targeting this enzyme, they say.

2 May 2014

New hope for improved diagnosis of children with TB

A distinctive genetic 'signature' found in the blood of children with tuberculosis (TB) offers new hope for improved diagnosis of the disease.

2 May 2014

HealthHIV: Nearly 50% of primary care providers lack knowledge about HIV treatment

Primary care providers who provide clinical HIV care (HIV PCPs) are experiencing rising HIV caseloads from newly insured patients under the Patient Protection and Affordable Care Act (PPACA), according to a national survey released today by HealthHIV.

2 May 2014

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

Northwestern Medicine- scientists have newly identified a protein's key role in cell and physiological aging and have developed - in collaboration with Tohoku University in Japan -- an experimental drug that inhibits the protein's effect and prolonged the lifespan in a mouse model of accelerated aging.

2 May 2014

EGPAF launches new training program to address health care worker shortages in Malawi

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is proud to launch a new training program to address health care worker shortages in Malawi. The program kicked-off today by enrolling students from 21 rural and remote areas of Malawi into a three-year training program to become nurse midwife technicians.

29 Apr 2014

Study to understand why YMSM place themselves at risk for HIV transmission

The number of new HIV infections in the United States had remained steady in recent years, but rates among urban millennial gay, bisexual, and other young men who have sex with men (YMSM) have steadily increased in the past decade.

29 Apr 2014

People with low cholesterol levels in immune cells experience slower HIV progression

People infected with HIV whose immune cells have low cholesterol levels experience much slower disease progression, even without medication, according to University of Pittsburgh Graduate School of Public Health research that could lead to new strategies to control infection.

29 Apr 2014

University of Michigan scientists uncover how cells block mutation-causing activity of junk DNA

There's a civil war going on inside every one of the 37 trillion cells in your body. Now, University of Michigan scientists have uncovered how your cells keep this war from causing too much collateral damage.

26 Apr 2014

HIV 1 News and Research

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Researchers discover genetic risk factor for premature birth

New United Nations data show sharp decline in maternal deaths

Nanoviricides develops new drug candidates against MERS infection

The Jeffrey Epstein VI Foundation supports Sunscreen Innovation Act to combat melanoma

Highlights: High Colo. insurance rate changes; La. hospital plan rejected; VA delays in care

Women who experience physical violence by partner are more likely to be smokers

Compounds in soy sauce can be 70 times more potent than first-line HIV drug Tenofovir

Alcohol consumption linked with increased risk of advanced liver fibrosis in HIV patients

New technique to examine how proteins interact at level of single HIV viral particle

Puzzle in breast cancer solved

UAMS receives $1.8M grant to lead new treatments for herpes viruses and cancers

Johns Hopkins biochemists figure out HIV-fighting activity of enzyme

New hope for improved diagnosis of children with TB

HealthHIV: Nearly 50% of primary care providers lack knowledge about HIV treatment

Scientists develop experimental drug that prolongs lifespan in mouse model of accelerated aging

EGPAF launches new training program to address health care worker shortages in Malawi

Study to understand why YMSM place themselves at risk for HIV transmission

People with low cholesterol levels in immune cells experience slower HIV progression

University of Michigan scientists uncover how cells block mutation-causing activity of junk DNA

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News